Feebris Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Feebris Ltd - overview
Established
2017
Location
Essex, -, UK
Primary Industry
Healthcare IT
About
Feebris Ltd develops innovative healthcare technology solutions that enhance community care through effective patient monitoring and management tools, utilizing advanced mobile applications and AI-driven insights. Feebris Ltd, founded in 2017 in Essex, UK, specializes in healthcare technology aimed at improving community care. The company has not undergone any noted strategic pivots or ownership changes. The founders, Adam Bacon and Elina Naydenova, have focused on integrating technology into healthcare workflows.
Feebris raised GBP 1. 1 million in Seed funding on May 29, 2019, from 24Haymarket and Innovate UK, marking its sole deal to date, with a total amount raised of GBP 1. 1 million. Feebris offers an advanced suite of healthcare technology solutions designed to enhance community care by enabling effective monitoring and management of vulnerable patients.
The core product is a mobile application that empowers community care teams to collect health data from multiple medical devices through a tailored clinical examination and triage process. This application generates risk scores and escalation recommendations based on the captured data, facilitating timely and informed clinical decisions. Notably, Feebris supports a variety of healthcare providers including nursing homes and care home managers, equipping them with AI-guided tools that streamline the process of capturing and sharing precise health measurements. The company's solutions are currently available to clients in various international markets.
Feebris operates on a subscription-based revenue model that caters to healthcare providers and organizations. Clients engage with the company through partnerships that allow them to integrate Feebris’ technology into their existing workflows, ensuring seamless access to the platform's features. Transactions typically involve recurring payments for access to the mobile application and associated services, which include user training and ongoing clinical quality assurance. The revenue structure supports diverse healthcare entities, particularly those focusing on community care, by providing essential tools that enhance patient monitoring and outcomes.
Following the recent Seed funding round in May 2019, Feebris Ltd plans to utilize the raised GBP 1. 1 million to enhance its product offerings and expand into new markets. The company is currently designing new features for its mobile application aimed at improving data analytics capabilities and user experience. Specific geographic regions for expansion include Europe and North America, with plans to establish a presence in these markets by late 2021.
Feebris aims to leverage its technology to facilitate better healthcare management globally.
Current Investors
24Haymarket, Innovate UK
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT, Cardiology
Website
www.feebris.com
Verticals
HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Feebris Ltd - employee data


Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.